Guinea-Bissau cancels trial, renewing challenge of protecting newborns from hepatitis B
Guinea-Bissau’s authorities have refused to allow a hepatitis B vaccine trial involving 14,000 newborns. The country plans to add a birth dose to its vaccination schedule by 2028.






















